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Medicine, and 4Hospital Pharmacy, Medical Center Leeuwarden, H. Dunantweg 2, 8934 AD Leeuwarden,
The NetherlandsWe present a case of a 51-year-old man, with an unusual occlusion of his brachial, radial and ulnar artery. Salvage of the
extremity was achieved with a saphenous vein bypass from the axillary artery to the brachial artery at the elbow and
subsequently a jump graft from the distal part of this bypass to the radial artery: histological analysis of the ulnar artery
showed constriction of the vascular lumen by media-hyperplasia reminiscent of the medial fibroplasias-subtype of
fibromuscular dysplasia. The brachial artery showed intimafibrosis and myxoid changes. These observations suggest a drug-
induced or toxic cause, most likely to have been caused by pergolide. The precise mechanisms by which pergolide mediates its
adverse vascular effects are unknown but may be related to ergotism. This type of side effect of pergolide has not been
described before.Keywords: Artery; Fibrosis; Pergolide; Ergotism.Introduction
Dopamine-agonists mainly stimulate the postsynaptic
dopamine receptors in a direct way,1,2 and can be used
in the treatment of patients with Parkinson’s disease.
The first dopamine-agonists were the ergotderivates
bromocriptine, lysuride and pergolide (Permaxw).
Later, the non-ergotderivates ropinirole, pramipexole
and cabergoline were introduced. Pergolide is being
used in The Netherlands since 1991 as monotherapy or
adjuvant therapy for symptomatic treatment of
patients with with Parkinson’s disease.
Besides peripheral side effects like orthostatic hypo-
tension, nausea and vomiting, also psychiatric side-
effects like hallucinations, psychoses and confusion can
occur.3 Other side-effects are constipation, edema of the
lower extremities and Raynaud’s phenomenon.3
Retroperitoneal fibrosis is rarely observed as a
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tine, methysergide, and pergolide.4–6 Pergolide-induced
pleuritis, pleuropulmonary fibrosis and valvular heart
disease have also been described.7,8 In retroperitoneal
fibrosis, pleuropulmonary fibrosis and valvular heart
disorders inadequate fibrosis takes place with secondary
loss of function of the specific organ. This may suggest a
common etiology. Lower extremity ischemia and arterial
spasm have been described in patients with ergotism.9,10
If patients continue the use of ergotamine, ischemia and
necrosis can be the result.
We report a case of a 51-year-old man, known with
Parkinson’s disease, who sustained brachial artery
obstruction thought to have been induced by pergo-
lide. Thus far, this possible type of side effect of
pergolide has not been described.Case ReportHistory
A 51-year-old male bank employee was seen in ourEJVES Extra 10, 8–11 (2005)
doi:10.1016/j.ejvsextra.2005.04.008, available online at http://www.sciencedirect.com onder CC BY-NC-ND license. 
Brachial Artery Obstruction 9department in June 2003 with complaints of a cold left
hand since 3 weeks, with tingling and signs of sensory
loss in his fingers and sometimes pain in his hand. He
noticed loss of grip strength. Recently, he was
diagnosed with Parkinson’s disease had started
pergolide (Permaxw) 4 months ago. He did not use
levodopa (Madopar or Sinemet).
His medical history included appendectomy, trans-
urethral resection of the prostate because of prostatic
hyperplasia, and epilepsy. Phenytoin was used until
2000. Since 2000, he complained of a tremor of his right
hand due to focal epilepsy of the left hemisphere.
Therefore, he was started on oxcarbazepine and
clonazepam. Because of mood disorders fluvoxamine
was also given. In 1983 he quitted smoking. He had a
normal diet and daily physical activity. His family
history was negative for vascular disease and venous
thromboembolism. An aunt was known to have
hypertension.Physical examination
Physical examination revealed a cold and cyanotic left
hand with more splinter hemorrhages on the left side
compared to the right side. The left radial and brachial
artery could not be palpated. There was atrophy of the
musculature of left hand and the patient was hardly
able to spread his fingers. The blood-pressure was
110/70 mmHg on the right side, and on the left side
the blood-pressure was not measurable. The right
radial artery pulse was just palpable. There were
no signs of a costoclavicular syndrome or other
features of an autoimmune disease. Chest and
cervical spine X-rays were made and showed no
abnormalities.Additional investigations
Blood and urine samples (fasting blood glucose and
lipidprofile, ANCA, thrombophily, protein C, protein
S, lipids, glucose, factor II mutation, factor V Leiden,
lubus anticoagulance, and hyperhomocystein) showed
no abnormalities. A cardial embolism was excluded by
echocardiography. No abnormalities were found by
the ophthalmologist. Echo-Doppler monitoring
showed no signals in the left upper-extremity.
Digital subtraction angiography (DSA) examination
showed complete obstruction of the left brachial
artery and proximal arteries of the lower arm (Fig.
1(A)–(C)). Angiography did not show any narrow-
ing or irregularity in the thoracic outlet area. There
were no signs of atherosclerosis or vasculitis.First operation
Since, there was no rest pain at first presentation an
operation was planned at short notice. A deterioration
on the day of admission required an emergency
operation. Initially we attempted a thrombectomy of
the brachial artery and both arteries of the lower arm.
No thrombus was found. However, stenoses in the
lumen of all arteries, including the brachial and
axillary arteries, could be felt. We initially did a
reversed left saphenous vein bypass from the axillary
artery to the brachial artery in the elbow, since the
attempted thrombectomy was abnormal from the
elbow upwards but the arteries below the elbow felt
fairly smooth. Good pulsations were felt both at the
radial and at the ulnar artery with restoration of the
circulation to the hand.Post-operative
Post-operative pulses were felt in the bypass as well as
distal from the bypass. A coumarin anticoagulant was
started. Six days after the initial operation, both the
radial and ulnar artery was pulseless. Echo-Doppler
monitoring showed a good arterial bypass flow with-
out vein bypass graft stenosis. There was no flow in
the ulnar artery and only a slight flow in the radial
artery. DSA showed a patent vein bypass graft. The
ulnar and distal radial arteries were completely
obstructed. There was collateral circulation to the
thumb, index and middle finger, but poor vascularisa-
tion to the fourth and little finger was seen. In contrast
to DSA, Echo-Doppler examination showed a patent
distal radial artery and multiple stenosis in the
proximal and distal part of the artery. To exclude any
influence of pergolide it was stopped and a second
operation was performed.Second operation
A second bypass was performed using the reversed
right greater saphenous vein from the distal part of the
former bypass to the distal part of the radial artery.
There was no pulsation in the ulnar artery and a
biopsy was taken from the ulnar artery for pathologi-
cal examination. Finally a fasciotomy was performed.Histopathological findings
Histological analysis of the ulnar artery revealed
constriction of the vascular lumen by media-hyper-
plasia, reminiscent to the lesion of the medialEJVES Extra Vol 10, July 2005
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There were no signs of vasculitis.
Analysis of the brachial artery sample revealed
mainly non-specific intimafibrosis with myxoid
changes. No signs of vasculitis were observed.Further course
A calcium channel blocker (Nifedipine) was started.
Good circulation of the left arm was achieved after the
second operation. Repeated blood and urine samples
showed no abnormalities. The patients had repeated
disabling extra-pyramidal symptoms. Therefore, the
neurologist started Requip in a low dose of 0.25 mg
four times a day. With time the right radial artery pulse
became normal. After a follow-up of 1 year, the patient
is symptom free and has normal distal pulses except
for the left ulnar artery.Discussion
Pergolide (Permaxw) is a dopamine-agonist (ergot
derivate) and can be used as monotherapy or adjuvant
therapy for symptomatic treatment of patients with
with Parkinson’s disease.
Several factors are associated with (sub)acute
brachial artery obstruction. One of the main causes
of arm artery disease is atherosclerosis. More uncom-
mon causes are thromboangiitis obliterans (Buerger’s
disease), Takayasu’s arteritis, Raynaud’s disease,
collagen vascular diseases (lupus, scleroderma, rheu-
matoid arthritis, and CREST syndrome), thoracic
outlet syndrome, thromboembolism, and drug treat-
ment. Hypertrophy of vascular intima and media has
been associated with levodopa therapy for Parkinson’s
disease and is related to hyperhomocysteinemia.11,12
Hyperhomocysteinemia was excluded in our patient.
A relationship between other medication used by our
patient and ergotism or other vascular disorders was
not found.
Fibromuscular dysplasia is a non-inflammatory
angiopathy of unknown cause.13 The histological
findings of the ulnar artery biopsy in our patient
were reiminisent of the medial fibroplasias-subtype of
fibromuscular dysplasia and suggested a medicine
related or a toxic cause. The brachial artery sample
showed non-specific fibrosis. As such histopathologi-
cal findings have been described in relation with
ergotism,13,14 We believe that these rare observationsFig. 1. Complete obstruction of the left brachial artery and
arteries of the lower arm.
Fig. 2. Constriction of the vascular lumen of the ulnar artery
by media-fibroplasia.
Brachial Artery Obstruction 11were pergolide induced ergotism. Pergolide, a dopa-
mine agonist, is an ergot derivate. A number of
adverse effects of ergotamine or other ergot derivates
as bromocriptine have also been described for pergo-
lide, such as retroperitoneal fibrosis,6 pleuropulmon-
ary fibrosis,7 and valvular heart disease.8 They have all
in common that fibrosis takes place with secondary
loss of function of the specific organ. The precise
mechanisms by which pergolide mediates its adverse
vascular effects are in fact unknown but may be related
in some way to fibrosis. However, the media fibropla-
sia as found in our patient is not likely to be associated
with these serosal fibroinflammatory syndromes. In
several case reports of patients with ergotism, lower
extremity ischemia and hyperplasia of the intima have
been described.9,10 In view of the relationship between
pergolide and ergotamine, the vascular disorders in
our patient could be attributed to pergolide. Further-
more, overall success was only achieved after the
second operation and after pergolide was discontin-
ued. Moreover, the radial artery pulse on the right,
non-operated side became normal again after pergo-
lide was stopped. Because this association a relation-
ship must be considered, although not proven, and
kept in mind by doctors prescribing this drug. In
the literature, no association between this type of
vascular disorder and pergolide have been described
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